Evidence map›Paper›PMID 31612321›Full record

ArticleJournal of neurology2020

ATP8A2-related disorders as recessive cerebellar ataxia.

Claire Guissart, Alexander N Harrison, Mehdi Benkirane, Ibrahim Oncel, Elif Acar Arslan, Anna K Chassevent, Kristin Baraῆano, Lise Larrieu, Maria Iascone, Romano Tenconi and 6 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Early-Onset Hyperkinetic Movement Disorders Define the Most Severe Presentation of the ATP8A2-Related Phenotypic Spectrum.International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. High rate of hypomorphic variants as the cause of inherited ataxia and related diseases: study of a cohort of 366 families.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 5 countries.

Claire GuissartLaboratoire de Génétique de Maladies Rares EA7402, Institut Universitaire de Recherche Clinique, Université de Montpellier, CHU Montpellier, 640 av. Doyen G. Giraud CEDEX 5, 34295, Montpellier, France. claire.guissart@inserm.fr.ORCID http://orcid.org/0000-0002-3944-5715
Alexander N HarrisonBiochemistry & Molecular Biology, University of British Columbia, Vancouver, Canada.
Mehdi BenkiraneLaboratoire de Génétique de Maladies Rares EA7402, Institut Universitaire de Recherche Clinique, Université de Montpellier, CHU Montpellier, 640 av. Doyen G. Giraud CEDEX 5, 34295, Montpellier, France.
Ibrahim OncelDepartment of Pediatric Neurology, Hacettepe University Children's Hospital, Ankara, Turkey.
Elif Acar ArslanDepartment of Pediatric Neurology, Karadeniz Technical University School of Medicine, Trabzon, Turkey.
Anna K ChasseventDepartment of Neurogenetics, Kennedy Krieger Institute, Baltimore, MD, USA.
Kristin BaraῆanoDepartment of Neurogenetics, Kennedy Krieger Institute, Baltimore, MD, USA.
Lise LarrieuLaboratoire de Génétique de Maladies Rares EA7402, Institut Universitaire de Recherche Clinique, Université de Montpellier, CHU Montpellier, 640 av. Doyen G. Giraud CEDEX 5, 34295, Montpellier, France.
Maria IasconeLaboratory of Genetic Medicine, ASST Papa Giovanni XXIII, Bergamo, Italy.
Romano TenconiDipartimento di Pediatria, Genetica Clinica, Università di Padova, Padova, Italy.
Mireille ClaustresLaboratoire de Génétique de Maladies Rares EA7402, Institut Universitaire de Recherche Clinique, Université de Montpellier, CHU Montpellier, 640 av. Doyen G. Giraud CEDEX 5, 34295, Montpellier, France.
Nesibe Eroglu-ErtugrulDepartment of Pediatric Neurology, Hacettepe University Children's Hospital, Ankara, Turkey.
Patrick CalvasDepartment of Clinical Genetics, Purpan University Hospital, Toulouse, France.
Haluk TopalogluDepartment of Pediatric Neurology, Hacettepe University Children's Hospital, Ankara, Turkey.
Robert S MoldayBiochemistry & Molecular Biology, University of British Columbia, Vancouver, Canada.
Michel KoenigLaboratoire de Génétique de Maladies Rares EA7402, Institut Universitaire de Recherche Clinique, Université de Montpellier, CHU Montpellier, 640 av. Doyen G. Giraud CEDEX 5, 34295, Montpellier, France.
Institut Universitaire de Recherche Clinique · FRHacettepe University Hospital · TRKennedy Krieger Institute · USUniversity of British Columbia · CACentre Hospitalier Universitaire de Toulouse · FRKaradeniz Technical University · TROspedale Papa Giovanni XXIII · ITUniversity of Padua · IT

Funding

Agence Nationale pour la Recherche (ANR)/E-rare Joint Trans-national Call (JTC) 2011 'Euro-SCAR' 2011-RARE-004-01CIHR PJT 148649
6 · The paper itself

Abstract

ATP8A2-related disorders are autosomal recessive conditions that associate encephalopathy with or without hypotonia, psychomotor delay, abnormal movements, chorea, tremor, optic atrophy and cerebellar atrophy (CARMQ4). Through a multi-centric collaboration, we identified six point mutations (one splice site and five missense mutations) involving ATP8A2 in six individuals from five families. Two patients from one family with the homozygous p.Gly585Val mutation had a milder presentation without encephalopathy. Expression and functional studies of the missense mutations demonstrated that protein levels of four of the five missense variants were very low and lacked phosphatidylserine-activated ATPase activity. One variant p.Ile215Leu, however, expressed at normal levels and displayed phospholipid-activated ATPase activity similar to the non-mutated protein. We therefore expand for the first time the phenotype related to ATP8A2 mutations to less severe forms characterized by cerebellar ataxia without encephalopathy and suggest that ATP8A2 should be analyzed for all cases of syndromic or non-syndromic recessive or sporadic ataxia.

Indexed as

Adenosine TriphosphatasesAdultCerebellar AtaxiaChildChild, PreschoolConsanguinityFemaleGenes, RecessiveHumansInfantMaleMutation, MissensePedigreePhenotypePhospholipid Transfer ProteinsPoint MutationAdenosine TriphosphatasesATP8A2 protein, humanPhospholipid Transfer ProteinsAtaxiaATP8A2CAMRQP4-ATPasePsychomotor delay

Identifiers

PMID31612321
OpenAlexW2981315920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.